Ramona Sequeira, age 54, has been a director of the Company since May 2020. Ms. Sequeira is currently the President of the US Business Unit and Global Portfolio Commercialization for Takeda Pharmaceutical Company. She has over 25 years of experience in the pharmaceutical industry through her work with Takeda and, prior to that, in various positions with Eli Lilly, including as Vice President – Lilly USA. She has led businesses in Canada, Europe and the U.S. and has extensive experience in leadership roles in multiple markets, across cultures and within different healthcare systems where she has successfully launched products, transformed businesses, and delivered sustainable growth. Ms. Sequeira participates in leadership forums to share her views on the role of trust and reputation in long-term company success and has led numerous executive development programs. Ms. Sequeira currently serves on the board of Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading innovative biopharmaceutical research companies, and has previously served on the board of the Association of the British Pharmaceutical Industry. Ms. Sequeira earned her MBA from McMaster University and received her Bachelor of Science in Molecular Genetics and Molecular Biology from the University of Toronto.